WAVERLEY PHARMA INC (WAVE.CA) Stock Price, Quote, News and Overview
TSX-V:WAVE - TSX Venture Exchange - CA94357L1058 - Common Stock - Currency: CAD
WAVE.CA Quote, Performance and Key Statistics
TSX-V:WAVE (6/9/2025, 7:00:00 PM)
0.015
-0.01 (-25%)
The current stock price of WAVE.CA is 0.015 CAD. In the past month the price increased by 50%. In the past year, price decreased by -57.14%.
WAVE.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 297.19M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 250.91M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 191.80M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 156.33M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 72.83M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 70.40M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 17.92 | 63.89M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 59.60M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 54.18M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 49.31M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 43.27M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 30.5 | 42.94M |
Related stock screener links
About WAVE.CA
Company Profile
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. The company is headquartered in Winnipeg, Manitoba. The company went IPO on 2017-04-27. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. The company has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.
Company Info
WAVERLEY PHARMA INC
4-1250 Waverley Street
Winnipeg MANITOBA R3T 6C6 CA
CEO: Larry Thiessen
Employees: 0
Phone: 12049287907
WAVERLEY PHARMA INC / WAVE.CA FAQ
What is the stock price of WAVERLEY PHARMA INC today?
The current stock price of WAVE.CA is 0.015 CAD. The price decreased by -25% in the last trading session.
What is the ticker symbol for WAVERLEY PHARMA INC stock?
The exchange symbol of WAVERLEY PHARMA INC is WAVE and it is listed on the TSX Venture Exchange exchange.
On which exchange is WAVE.CA stock listed?
WAVE.CA stock is listed on the TSX Venture Exchange exchange.
What is WAVERLEY PHARMA INC worth?
WAVERLEY PHARMA INC (WAVE.CA) has a market capitalization of 810.00K CAD. This makes WAVE.CA a Nano Cap stock.
How many employees does WAVERLEY PHARMA INC have?
WAVERLEY PHARMA INC (WAVE.CA) currently has 0 employees.
What are the support and resistance levels for WAVERLEY PHARMA INC (WAVE.CA) stock?
WAVERLEY PHARMA INC (WAVE.CA) has a support level at 0.01 and a resistance level at 0.02. Check the full technical report for a detailed analysis of WAVE.CA support and resistance levels.
Should I buy WAVERLEY PHARMA INC (WAVE.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of WAVE.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of WAVE.CA, evaluating the profitability, health, valuation and growth aspects
- WAVERLEY PHARMA INC (WAVE.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- WAVERLEY PHARMA INC (WAVE.CA) Sales and EPS estimates to see what analysts future expectations are.
- WAVERLEY PHARMA INC (WAVE.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- WAVERLEY PHARMA INC (WAVE.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- WAVERLEY PHARMA INC (WAVE.CA) Stock Chart to make your own analysis
- WAVERLEY PHARMA INC (WAVE.CA) Latest news and press-releases to stay up to date.
Does WAVERLEY PHARMA INC (WAVE.CA) stock pay dividends?
WAVE.CA does not pay a dividend.
When does WAVERLEY PHARMA INC (WAVE.CA) report earnings?
WAVERLEY PHARMA INC (WAVE.CA) will report earnings on 2025-08-25.
What is the Price/Earnings (PE) ratio of WAVERLEY PHARMA INC (WAVE.CA)?
WAVERLEY PHARMA INC (WAVE.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
WAVE.CA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to WAVE.CA. When comparing the yearly performance of all stocks, WAVE.CA is a bad performer in the overall market: 91.14% of all stocks are doing better.
WAVE.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to WAVE.CA. WAVE.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
WAVE.CA Financial Highlights
Over the last trailing twelve months WAVE.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 57.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.29% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |